Profound Urinary Protein Loss and Acute Renal Failure Caused by Cyclooxygenase-2 Inhibitor

10.4077/CJP.2011.AMM062

Yu-Hsin Chen；Der-Cherng Tarng

acute renal failure ； cyclooxygenase-2 COX-2 inhibitors ； minimal change disease

The Chinese Journal of Physiology

54卷4期（2011 / 08 / 01）

264 - 268

英文

Cumulative evidence has shown that nonsteroidal anti-inflammatory drugs (NSAIDs) can induce acute renal failure and nephrotic-range proteinuria. Cyclooxygenase-2 (COX-2) inhibitors have less nephrotoxicity; however, recent data indicate that they may cause the same renal problems as NSAIDs do. Herein, we present a case of celecoxib-associated minimal change disease (MCD) with profound urinary protein loss and acute renal failure. Renal function and nephrotic syndrome in this patient resolved completely after discontinuation of celecoxib and treatment with methylprednisolone. Clinicians should keep high index of suspicions in patients developing nephrotic syndrome and acute renal failure after taking COX-2 inhibitors since secondary MCD responds well to timely cessation of COX-2 inhibitors and administration of steroid therapy.

1. Abraham, P. A.,Keane, W. F.(1984).Glomerular and interstitial disease induced by nonsteroidal anti-inflammatory drugs.Am. J. Nephrol.,4,1-6.
2. Almansori, M.,Kovithavongs, T.,Qarni, M. U.(2005).Cyclooxygenase- 2 inhibitor-associated minimal-change disease.Clin. Nephrol.,63,381-384.
3. Alper, A. B. Jr.,Meleg-Smith, S.,Krane, N. K.(2002).Nephrotic syndrome and interstitial nephritis associated with celecoxib.Am. J. Kidney Dis.,40,1086-1090.
4. Brater, D. C.(1999).Effects of nonsteroidal anti-inflammatory drugs on renal function: focus on cyclooxygenase-selective inhibition.Am. J. Med.,107,65S-71S.
5. Carmichael, J.,Shankel, S. W.(1985).Effects of nonsteroidal antiinflammatory drugs on prostaglandins and renal function.Am. J. Med.,78,992-1000.
6. Cheng, H. F.,Wang, J. L.,Zhang, M. Z.,McKanna, J. A.,Harris, R. C.(2000).Role of p38 in the regulation of renal cortical cyclooxygenase- 2 expression by extracellular chloride.J. Clin. Invest.,106,681-688.
7. Clive, D. M.,Stroff, J. S.(1984).Renal syndromes associated with nonsteroidal anti-inflammatory drugs.N. Engl. J. Med.,310,563- 572.
8. Garella, S.,Matarese, R. A.(1984).Renal effects of prostaglandins and clinical adverse effects of nonsteroidal anti-inflammatory agents.Medicine,63,165-181.
9. Komers, R.,Anderson, S.,Epstein, M.(2001).Renal and cardiovascular effects of selective cyclooxygenase-2 inhibitors.Am. J. Kidney Dis.,38,1145-1157.
10. Markowitz, G. S.,Falkowitz, D. C.,Isom, R.,Zaki, M.,Imaizumi, S.,Appel, G. B.,D''Agati, V. D.(2003).Membranous glomerulopathy and acute interstitial nephritis following treatment with celecoxib.Clin. Nephrol.,59,137-142.
11. Neilson, E. G.(1989).Pathogenesis and therapy of interstitial nephritis.Kidney Int.,35,1257.
12. Perazella, M. A.,Eras, J.(2000).Are selective COX-2 inhibitors nephrotoxic?.Am. J. Kidney Dis.,35,937-940.
13. Takei, T.,Koike, M.,Suzuki, K.,Shirota, S.,Itabashi, M.,Ohtsubo, S.,Sugiura, H.,Suzuki, K.,Kojima, C.,Takahashi, M.,Ino, J.,Ogawa, T.,Uchida, K.,Tsuchiya, K.,Yumura, W.,Nitta, K.(2007).The characteristics of relapse in adult-onset minimal-change nephrotic syndrome.Clin. Exp. Nephrol.,11,214-217.
14. Whelton, A.(1999).Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications.Am. J. Med.,106,13S-24S.
15. Woywodt, A.,Schwarz, A.,Mengel, M.,Haller, H.,Zeidler, H.,Köhler, L.(2001).Nephrotoxicity of selective COX-2 inhibitors.J. Rheumatol.,28,2133-2135.

1. Zivkovic, Vladimir,Vuletic, Milena,Stojimirovic, Biljana,Pesic, Snezana,Milinkovic, Marija,Jakovljevic, Vladimir,Djuric, Dragan,Barudzic, Nevena(2015).Assessment of Oxidative Status in Patients with Acute Kidney Injury: A Pilot Study.中國生理學雜誌,58(2),124-133.